Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab
Short Report
[키워드] absence
acute respiratory syndrome
Anti-CD20 antibodies
Anti-CD20 antibody
anti-SARS-CoV-2 antibody
antibody
Antibody testing
asymptomatic phase
Clinical course
contributed
COVID-19
disease
disease-associated
dose
Evolution
feature
first symptom
generate
IgG
IgM
immune
immunodeficiency
Infection
lymphoma
management
mantle cell
mantle cell lymphoma
mechanism of action
molecular
Nasopharyngeal swab
NHL
nine
Occurrence
overlapped
Pandemics
Patient
patients
repeated
rituximab
RNA
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 vaccine
serology
severe COVID-19
subject
Symptom
Treatment
turn
unique
Viral RNA
virus
while
[DOI] 10.1186/s13027-021-00376-1 PMC 바로가기 [Article Type] Short Report
[DOI] 10.1186/s13027-021-00376-1 PMC 바로가기 [Article Type] Short Report